As demonstrated in Figure 3, the high p‐tau217 profiles were most commonly seen in AD (total 88% of AD, 60% high p‐tau217/high NfL, and 28% high p‐tau217/low NfL biomarker profiles). Here, NEFL is linked to Alzheimer disease.